MyEG to be appointed sole distributor of Zhifei vaccine in Malaysia

KUALA LUMPUR: My E.G. Services Bhd has entered into a memorandum of understanding with Anhui Zhifei Longcom Biopharmaceutical Co, Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.